• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 3. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526

Research Briefing on Diethylisobutyroylmalonate (CAS: 21633-78-3) in Chemical and Biomedical Applications

Diethylisobutyroylmalonate (CAS: 21633-78-3) is a specialized chemical compound with significant applications in organic synthesis and pharmaceutical research. Recent studies have highlighted its role as a versatile intermediate in the synthesis of complex molecules, particularly in the development of bioactive compounds and drug candidates. This briefing provides an overview of the latest research advancements involving this compound, focusing on its synthetic utility, mechanistic insights, and potential biomedical applications.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers explored the use of Diethylisobutyroylmalonate as a key building block for the synthesis of novel heterocyclic compounds with antimicrobial properties. The study demonstrated that derivatives of this compound exhibited promising activity against multidrug-resistant bacterial strains, suggesting its potential in addressing the global challenge of antibiotic resistance. The synthetic pathway involved a series of condensation and cyclization reactions, with Diethylisobutyroylmalonate serving as a critical precursor.

Another significant development was reported in a 2024 preprint on bioRxiv, where Diethylisobutyroylmalonate was utilized in the design of prodrugs for targeted cancer therapy. The researchers modified the compound to enhance its solubility and bioavailability, enabling its incorporation into liposomal delivery systems. Preliminary in vitro and in vivo studies showed improved tumor-targeting efficiency and reduced off-target effects, underscoring the compound's potential in oncology drug development.

Mechanistic studies have also shed light on the reactivity of Diethylisobutyroylmalonate. A recent computational chemistry analysis, published in Organic & Biomolecular Chemistry, investigated the compound's electronic structure and reaction pathways. The findings revealed that its unique steric and electronic properties facilitate selective bond formation, making it a valuable tool for asymmetric synthesis. This insight has implications for the design of chiral pharmaceuticals and agrochemicals.

From an industrial perspective, advancements in the scalable synthesis of Diethylisobutyroylmalonate have been reported by several chemical manufacturers. Innovations in catalytic processes and green chemistry approaches have reduced production costs and environmental impact, as highlighted in a 2023 technical report by a leading fine chemicals supplier. These developments are expected to increase the compound's accessibility for research and commercial applications.

Looking ahead, ongoing research is exploring the use of Diethylisobutyroylmalonate in emerging areas such as peptide mimetics and polymer chemistry. Its structural flexibility and functional group compatibility position it as a promising candidate for diverse applications. However, challenges remain in optimizing its stability and reactivity profiles for specific use cases, as noted in recent patent filings.

In conclusion, Diethylisobutyroylmalonate (21633-78-3) continues to demonstrate significant value in chemical and biomedical research. The compound's versatility as a synthetic intermediate, combined with recent breakthroughs in its applications, underscores its importance in drug discovery and materials science. Future research directions may focus on expanding its utility in targeted drug delivery systems and sustainable chemical processes.

• 61337-00-6(Propanedioic acid, (3-methyl-2-oxobutyl)-, diethyl ester)
• 23193-18-2(1,3-diethyl 2-(2-oxopropyl)propanedioate)
• 24514-82-7(Propanedioic acid,2-(1-oxooctadecyl)-, 1,3-diethyl ester)
• 66952-02-1(Propanedioic acid, (1-oxohexyl)-, diethyl ester)
• 4761-26-6(Ethyl 2-\u200bCarbethoxy-\u200b5-\u200bketohexanoate)
• 92373-14-3(Triethyl 2-oxopentane-1,1,5-tricarboxylate)
• 70184-67-7(1,1,4-Butanetricarboxylicacid, 3-oxo-, 1,1,4-triethyl ester)
• 3378-01-6(Propanedioic acid,2-acetyl-2-ethyl-, 1,3-diethyl ester)
• 5431-94-7( )
• 21633-77-2(1,3-diethyl 2-propanoylpropanedioate)